{"result": "(\"entity\"<|>SNO<|>ORGANIZATION<|>SNO refers to specific nutritional supplements used for patients with diabetes and cancer to address nutritional deficiencies.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that can increase the risk of developing pancreatic cancer and is associated with significant weight loss in patients.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPLEMENTATION<|>EVENT<|>Nutritional supplementation is a treatment approach aimed at improving the nutritional status of patients, particularly those with cancer.)\n##\n(\"relationship\"<|>SNO<|>NUTRITIONAL SUPPLEMENTATION<|>SNO is a type of nutritional supplementation used to improve the health of patients with diabetes and cancer<|>8)\n##\n(\"relationship\"<|>DIABETES<|>PANCREATIC CANCER<|>Diabetes is a risk factor for developing pancreatic cancer, with increased likelihood based on the duration of the condition<|>7)\n##\n(\"relationship\"<|>DIABETES<|>CANCER<|>Diabetes is associated with a higher risk of various cancers, including pancreatic and gastric cancers<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ulina con el infusor\n                JNA BASAL (24 h8r\n         HORAS\n                            65             0.70              0a0\n                                           0.7*              7-80\n                          0.40             0.60                40\n         10-1u              80               90              1.16\n                            70               26              0 7\n         21-0             0.70              0 70             0.70\n         UI    INBULINNR HC                                                Pautas del infusor (BICI)\n         u           0 *\n         2                                                     UI                  durante el\n         Cr          D *                      UI                                  seguimiento\n         Faeror                             Fs   0-10         40\n                                                  10-27\n                                                 21-0         60\n         suplomontcion bolo Preinger\n         200        220   30.6 DI\n         220        250      0.UI\n         250        300   42.0.Ul\n         300        350   43.0 UI\n                                                                                                      177\n---\n     Tabla 5: variabilidad glucémica\n                                                    1Ju\n                                                    456\n                                                                                         Monitorización\n                                                                                         de la glucemia\n                                                                                         con FREE-STYLE\n         Iuda                                       200\n              Se inicia tratamiento nutricional con SNO específicos de DM al conocer el diag-\n     nóstico y evaluar al paciente, con disminución inicial ponderal leve y posterior dismi-\n     nución severa, aun con la suplementación (Tabla 6).\n\n\n\n     Tabla 6: intervención nutricional con SNO\n                                             SNO utilizados\n                       ESPECIFICO         SNO         calorias    proteinas     fibra soluble\n                        volumen         zo0ml        320 Kcal        18gr            5 gr           2018\n                                        400ml        640 Kcal        3680           10gr\n                          Hc[HP         600 ml       960 Kcal        54gr           15gr\n                                        sooml        1280Kcal        72gr           20gr\n                       NO\n                       ESPECIFICO         SNO        calorias     preteinas     fibra soluble       2012\n                        volumen         200ml        200Kcal         8gr            3,4g5\n                          NCINP         400 ml       400 Kcal        16e0_          38er_\n                Calorias      73 X30:       2190 Kcal               58% del aporte calorico SNO\n                  Proteinas     1,5x73:        109 gr              66% del aporte proteico SNO\n     Discusión\n              Se sabe que la mayor prevalencia de desnutrición hospitalaria ocurre en el pa-\n     ciente oncológico, según los resultados del estudio PREDYCES, realizado en nuestros\n     hospitales, con 33,9% de pacientes desnutridos al ingreso y un 36,4% al alta4 . El estado\n     nutricional en el paciente oncológico es un factor de riesgo de recurrencia de la enfer-\n     medad y, en algunas series, la malnutrición duplica este riesgo y es un fuerte predictor\n     de su calidad de vida5 . Por ello, ESPEN y otras asociaciones profesionales recomiendan,\n     el cribado nutricional, la evaluación y el tratamiento nutricional en estos pacientes6 .\n178\n---\n         También, en 26% de los canceres pancreáticos y 30-38% de los cánceres gástri-\ncos se originan las mayores pérdidas ponderales, superiores al 10% del peso inicial. Por\nello, los objetivos primarios de la nutrición en el cáncer tratan de corregir o prevenir las\ndeficiencias nutricionales, el fallecimiento prematuro secundario a la desnutrición,\nmejorar la tolerancia y la respuesta tumoral al tratamiento y optimizar la calidad de\nvida del paciente7 . El soporte nutricional trata de frenar el incremento de morbi-morta-\nlidad secundaria a los tratamientos oncológicos, para evitar la caquexia cancerosa una\nsituación clínica sin respuesta al tratamiento nutricional con predominio de la situa-\nción catabólica que va a disminuir su calidad de vida.\n\n\n\n         Algunos metaanálisis en pacientes con cáncer demuestran que la suplementa-\nción oral mejora la calidad de vida de los pacientes oncológicos, con disminución en\nlos pacientes con riesgo nutricional de todas las complicaciones y, sobre todo, de las\ninfecciosas8 .\n         Estos tumores ocasionan con gran frecuencia diabetes. Se sabe que el riesgo\nrelativo de Ca páncreas es 2,11 veces mayor en diabéticos con más de dos años de\nevolución de la enfermedad y existe un incremento de 4.43 veces, si la diabetes ha\naparecido dos años antes. La historia familiar también aumenta el riego 11,04 veces9 y\nla obesidad mórbida, lo incrementa 2,61 veces en\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>PREDYCES<|>ORGANIZATION<|>PREDYCES is a study conducted in hospitals that assessed the prevalence of malnutrition among oncology patients, revealing significant rates of malnutrition at admission and discharge.)\n##\n(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is a professional association that recommends nutritional screening, evaluation, and treatment for oncology patients.)\n##\n(\"entity\"<|>CANCER<|>EVENT<|>Cancer is a disease that significantly impacts nutritional status and can lead to malnutrition, affecting patient outcomes and quality of life.)\n##\n(\"entity\"<|>PANCREATIC CANCER<|>EVENT<|>Pancreatic cancer is associated with high rates of weight loss and nutritional deficiencies, impacting patient health.)\n##\n(\"entity\"<|>GASTRIC CANCER<|>EVENT<|>Gastric cancer is another type of cancer that leads to significant weight loss and nutritional challenges for patients.)\n##\n(\"entity\"<|>CAQUEXIA CANCEROSA<|>EVENT<|>Caquexia cancerosa is a clinical condition characterized by severe weight loss and muscle wasting in cancer patients, often unresponsive to nutritional treatment.)\n##\n(\"relationship\"<|>PREDYCES<|>ESPEN<|>PREDYCES study results align with ESPEN's recommendations for nutritional management in oncology patients<|>7)\n##\n(\"relationship\"<|>CANCER<|>PANCREATIC CANCER<|>Pancreatic cancer is a type of cancer that leads to significant nutritional issues and weight loss<|>8)\n##\n(\"relationship\"<|>CANCER<|>GASTRIC CANCER<|>Gastric cancer is another type of cancer that leads to significant nutritional issues and weight loss<|>8)\n##\n(\"relationship\"<|>PANCREATIC CANCER<|>CAQUEXIA CANCEROSA<|>Pancreatic cancer can lead to caquexia cancerosa due to severe weight loss and muscle wasting<|>9)\n##\n(\"relationship\"<|>GASTRIC CANCER<|>CAQUEXIA CANCEROSA<|>Gastric cancer can also lead to caquexia cancerosa due to severe weight loss and muscle wasting<|>9)\n<|COMPLETE|>"}]}